Browse a selection of photos from the American College of Cardiology's annual meeting in New Orleans. The pictures highlight key moments, new technologies and much more from the big show. 

The annual list, now in its 17th year, was designed to celebrate companies that make ethical business practices a high priority. 

Although advanced imaging exams have proven benefits in defining disease severity, new data indicate that more sophisticated studies might not impact outcomes as much as previously thought. 

SCAI and the Association of Black Cardiologists have joined forces to share a simple message: PAD patients would be negatively impacted by new CMS proposals. 

SGLT2 inhibitors such as dapagliflozin and empagliflozin are associated with improved outcomes among many heart failure patients. The medications are not cost-effective, however, limiting their overall value. Read the full economic analysis to learn more. 

Many patients who would clearly benefit by lowered LDL cholesterol levels are choosing to forgo first-time recommendations for statin regimens, according to a population-level study. 

Also, researchers noted, cryoballoon ablation was linked to a lower risk of cardiac tamponade than radiofrequency ablation. The study included data from nearly 60,000 hospitalizations.

As much as TAVR's popularity has grown in recent years, there are still many instances when a heart team may find that surgery offers the best path forward.